MedTrace Logo

Perinatal Nurse Home Visiting Enhanced With mHealth Technology

NCT01688427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 433

Last updated 2019-03-06

No results posted yet for this study

Summary

This research is being done to test whether mobile technology will reduce possible communication barriers between women and their home visitor; to improve assessing for health problems that could affect their pregnancy; to help in the delivery of information and actions to improve the health of the woman and their child.

Conditions

  • Domestic Violence
  • Intimate Partner Violence

Interventions

BEHAVIORAL

Standard IPV Assessment

Test the effectiveness of the eMOCHA DOVE application using mHealth technology for routine assessment of IPV vs. Pencil and paper at enrollment, delivery, and 2 months post birth.

BEHAVIORAL

Standard DOVE Intervention

Intervention will be administered via eMOCHA tablet vs. home visitor over 6 sessions in 6 months.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Phyllis W Sharps, PhD · Johns Hopkins University, School of Nursing

  • Linda Bullock, PhD, RN · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2016-09-30
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01688427 on ClinicalTrials.gov